Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis
Abstract Pancreatic cancer (PC) has high lethality due to multiple reasons, and its limited response to conventional chemotherapy like gemcitabine (GEM) is a non-negligible one. Therefore, our study introduces Chlorophyllin (CHL) as an effective therapeutic candidate to enhance the therapeutic effic...
Saved in:
| Main Authors: | Jiaqiang Ren, Tong Su, Jiachun Ding, Fan Chen, Jiantao Mo, Jie Li, Zheng Wang, Liang Han, Zheng Wu, Shuai Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01180-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
by: REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng
Published: (2024-12-01) -
Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01) -
Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy
by: Wang D, et al.
Published: (2024-12-01) -
Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01) -
Cuproptosis-driven nanostrategies: Synergistic nanoplatforms for tumor microenvironment reprogramming and enhanced anticancer efficacy
by: Haipeng Cheng, et al.
Published: (2025-06-01)